In a study by Huang et al., the authors performed a comprehensive analysis examining the correlation between CD47 expression and OS across 33 cancer types and demonstrated that elevated CD47 expression was indicative of a poorer survival outcome in malignancies, such as pancreatic adenocarcinoma or kidney renal papillary cell carcinoma. This evidence concerns the gene CD47 and cancer.